Pembrolizumab (Immunotherapy)
Treatment used for 3 conditions
Total Trials
81
Total Participants
75K
Avg Effectiveness
63%
Avg Safety Score
52%
Conditions Treated
Click on a condition to view detailed treatment information and clinical trial data.
Treatment used for 3 conditions
Click on a condition to view detailed treatment information and clinical trial data.